Dr Cheryl Keech | Chief Medical Officer And Executive Vice President Of Clinical Research ILiAD Biotechnologies, LLC
Appearances:
Day 2, April 8 @ 11:40
Results from the Ph2 trial of BPZE1 intranasal pertussis vaccine in healthy adults - Assessing immunity and safety using a prime or prime+boost schedule